Urology · Richmond, VA
NPI
1609830165
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
9101 Stony Point Dr
Richmond, VA, 23235
Phone (804) 330-9105
Groups this clinician bills Medicare through
Medicare paid, 2024
$261K
14,672 services
Medicare patients, 2024
1,199
Average age 76
Drug cost, 2024
$490K
3,538 prescriptions
Company payments, 2025
$2,666
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert D Brown was code 99214 (office e&m - established), 1,283 times for 781 patients. In total Robert D Brown billed 14,672 services in 76 codes, and Medicare paid $261K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,283 | 781 | $92.20 | $118K |
| 81002 Clinical Chemistry | Office | 807 | 583 | $3.40 | $2,740 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 609 | 473 | $12.26 | $7,468 |
| 81000 Clinical Chemistry | Office | 577 | 409 | $3.93 | $2,266 |
| 51798 Ultrasound - Nonspecific | Office | 572 | 446 | $8.08 | $4,623 |
| 36415 Venipuncture Blood Collection | Office | 487 | 380 | $8.63 | $4,204 |
| 84153 Clinical Chemistry | Office | 399 | 317 | $17.89 | $7,139 |
| 74018 Standard X-ray | Office | 369 | 275 | $21.86 | $8,066 |
| 99213 Office E&M - Established | Office | 214 | 209 | $63.36 | $14K |
| 99204 Office E&M - New | Office | 145 | 145 | $114.58 | $17K |
| 52000 Cystourethroscopy | Office | 86 | 78 | $178.38 | $15K |
| 76872 Ultrasound - Nonspecific | Facility | 71 | 71 | $23.60 | $1,675 |
| 55700 Other Organ Systems | Facility | 71 | 71 | $92.10 | $6,539 |
| 84403 Clinical Chemistry | Office | 60 | 49 | $24.93 | $1,496 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 56 | 16 | $48.46 | $2,714 |
By year: 2022 $278K for 19,938 services; 2023 $272K for 16,601 services; 2024 $261K for 14,672 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 807 | 583 | $3.40 | $2,740 |
| 81000 Clinical Chemistry | 577 | 409 | $3.93 | $2,266 |
| 36415 Venipuncture Blood Collection | 487 | 380 | $8.63 | $4,204 |
| 84153 Clinical Chemistry | 399 | 317 | $17.89 | $7,139 |
| 84403 Clinical Chemistry | 60 | 49 | $24.93 | $1,496 |
Medicare prescription drug claims, 2024
In 2024, the drug Robert D Brown prescribed most often to Medicare patients was Finasteride, with 871 prescriptions and refills. In total Robert D Brown wrote 3,538 Medicare prescriptions that cost $490K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Finasteride Generic | 871 | 2,409 | 267 | $11K |
| Tamsulosin Hcl Generic | 808 | 2,105 | 297 | $10K |
| Cefuroxime Cefuroxime Axetil | 384 | 384 | 220 | $5,959 |
| Myrbetriq Mirabegron | 242 | 486 | 72 | $217K |
| Tolterodine Tartrate Generic | 148 | 338 | 50 | $16K |
| Estradiol Generic | 135 | 270 | 98 | $8,481 |
| Ciprofloxacin Hcl Generic | 98 | 98 | 87 | $254 |
| Tadalafil Generic | 68 | 182 | 20 | $17K |
| Tolterodine Tartrate Er Tolterodine Tartrate | 66 | 124 | 16 | $6,990 |
| Doxycycline Monohydrate Generic | 58 | 58 | 44 | $733 |
| Cefdinir Generic | 57 | 57 | 51 | $430 |
| Cephalexin Generic | 55 | 83 | 18 | $315 |
| Gemtesa Vibegron | 43 | 83 | 14 | $39K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 41 | 41 | 25 | $72.29 |
| Ketorolac Tromethamine Generic | 37 | 37 | 32 | $382 |
Brand drugs: - claims; generic drugs: 3,167 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert D Brown $2,666 ($2,666 in general payments such as food, travel and fees) from 23 companies. The largest payer was Dendreon Pharmaceuticals LLC with $295.
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 10 | $295 |
| Janssen Biotech, Inc. JNJ | 13 | $289 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 9 | $248 |
| Astellas Pharma US Inc 4503.T | 9 | $234 |
| Endo USA, Inc. | 8 | $188 |
| Abbvie Inc. ABBV | 8 | $170 |
| Sumitomo Pharma America, Inc. 4506.T | 7 | $167 |
| Progenics Pharmaceuticals, Inc. | 9 | $162 |
| Novartis Pharmaceuticals Corporation NVS | 8 | $150 |
| Procept Biorobotics Corporation PRCT | 1 | $133 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.